Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Killip MJ"'
Deletion or truncation of NS1, the principal interferon (IFN) antagonist of influenza viruses, leads to increased IFN induction during influenza virus infection. We have studied activation of the IFN induction cascade by both wildtype and NS1-defecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7ced49725b5ce67f8187bcd287f8bad9
https://hdl.handle.net/10023/10527
https://hdl.handle.net/10023/10527
Autor:
Pérez-Cidoncha, M, Killip, MJ, Oliveros, JC, Asensio, VJ, Fernández, Y, Bengoechea, JA, Randall, RE, Ortín, J
Influenza A viruses counteract the cellular innate immune response at several steps, including blocking RIG I-dependent activation of interferon (IFN) transcription, IFN-dependent upregulation of IFN-stimulated genes (ISGs) and the activity of variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7c21e3cfa7a7bffed6077cc3798bfb46
https://hdl.handle.net/10023/4873
https://hdl.handle.net/10023/4873
It is generally thought that pathogen-associated molecular patterns (PAMPs) responsible for triggering interferon (IFN) induction are produced during virus replication and, to limit the activation of the IFN response by these PAMPs, viruses encode an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a21c153d9a573f55033d0500c630fd7f
https://openaccess.sgul.ac.uk/id/eprint/101043/1/1-s2.0-S0042682211001528-main.pdf
https://openaccess.sgul.ac.uk/id/eprint/101043/1/1-s2.0-S0042682211001528-main.pdf
Autor:
Seymour DW; York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Forshaw G; York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Porteous M; York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Mawer D; York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Wiggins F; York Trials Unit, Department of Health Sciences, ARRC Building, University of York, Heslington, York, YO10 5DD, UK., Mitchell A; York Trials Unit, Department of Health Sciences, ARRC Building, University of York, Heslington, York, YO10 5DD, UK., Hewitt C; York Trials Unit, Department of Health Sciences, ARRC Building, University of York, Heslington, York, YO10 5DD, UK., Beetar-King T; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Davies KA; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Jackson D; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Hannah MJ; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Pitcher M; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Arnold U; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Strachan R; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Killip MJ; High Containment Microbiology, United Kingdom Health Security Agency, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Nixon PJ; York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK.
Publikováno v:
Access microbiology [Access Microbiol] 2024 Jul 08; Vol. 6 (7). Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).
Autor:
Davies K; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Arnold U; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Buczkowski H; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Burton C; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Welch SR; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Green N; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Strachan R; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Beetar-King T; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Spencer P; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Hettiarachchi N; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Hannah MJ; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Jones M; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Cane PA; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Bruce CB; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Woodford N; NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Roberts ADG; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK., Killip MJ; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, London, NW9 5EQ, UK. marian.killip@phe.gov.uk.
Publikováno v:
Scientific reports [Sci Rep] 2021 Dec 03; Vol. 11 (1), pp. 23379. Date of Electronic Publication: 2021 Dec 03.
Autor:
Davies K; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Buczkowski H; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Welch SR; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Green N; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Mawer D; York Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Woodford N; National Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, NW9 5EQ, London, UK., Roberts ADG; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK., Nixon PJ; York Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Seymour DW; York Hospitals NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK., Killip MJ; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, 61 Colindale Avenue, Colindale, London, NW9 5EQ, UK.
Publikováno v:
The Journal of general virology [J Gen Virol] 2021 Apr; Vol. 102 (4).
Autor:
Welch SR; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Davies KA; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Buczkowski H; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Hettiarachchi N; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Green N; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Arnold U; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom.; UK Public Health Rapid Support Team, Public Health England/London School of Hygiene and Tropical Medicine, London, United Kingdom., Jones M; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Hannah MJ; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Evans R; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Burton C; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Burton JE; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Guiver M; Virology Department, Clinical Sciences Laboratory, National Infection Service, Public Health England, Manchester Public Health Laboratory, Manchester, United Kingdom., Cane PA; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Woodford N; NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Bruce CB; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Roberts ADG; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom., Killip MJ; High Containment Microbiology, NIS Laboratories, National Infection Service, Public Health England, Colindale, London, United Kingdom marian.killip@phe.gov.uk.
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2020 Oct 21; Vol. 58 (11). Date of Electronic Publication: 2020 Oct 21 (Print Publication: 2020).
Autor:
Te Velthuis AJW; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. ajwt6@cam.ac.uk.; Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. ajwt6@cam.ac.uk., Long JC; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Bauer DLV; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Fan RLY; School of Public Health, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Yen HL; School of Public Health, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Sharps J; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Siegers JY; Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands., Killip MJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.; Biomedical Sciences Research Complex, North Haugh, University of St Andrews, St Andrews, UK., French H; Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Oliva-Martín MJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Randall RE; Biomedical Sciences Research Complex, North Haugh, University of St Andrews, St Andrews, UK., de Wit E; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., van Riel D; Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands., Poon LLM; School of Public Health, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Fodor E; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. ervin.fodor@path.ox.ac.uk.
Publikováno v:
Nature microbiology [Nat Microbiol] 2018 Nov; Vol. 3 (11), pp. 1234-1242. Date of Electronic Publication: 2018 Sep 17.
Single-cell studies of IFN-β promoter activation by wild-type and NS1-defective influenza A viruses.
Autor:
Killip MJ; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.; School of Biology, Biomedical Sciences Research Complex, North Haugh, University of St. Andrews, Fife KY16 9ST, UK., Jackson D; School of Biology, Biomedical Sciences Research Complex, North Haugh, University of St. Andrews, Fife KY16 9ST, UK., Pérez-Cidoncha M; School of Biology, Biomedical Sciences Research Complex, North Haugh, University of St. Andrews, Fife KY16 9ST, UK., Fodor E; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK., Randall RE; School of Biology, Biomedical Sciences Research Complex, North Haugh, University of St. Andrews, Fife KY16 9ST, UK.
Publikováno v:
The Journal of general virology [J Gen Virol] 2017 Mar; Vol. 98 (3), pp. 357-363. Date of Electronic Publication: 2017 Mar 20.
Autor:
Killip MJ; Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, UK; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK. Electronic address: mjk3@st-andrews.ac.uk., Fodor E; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK., Randall RE; Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, UK.
Publikováno v:
Virus research [Virus Res] 2015 Nov 02; Vol. 209, pp. 11-22. Date of Electronic Publication: 2015 Feb 09.